Multiple Sclerosis News Today

Developer granted patent in Japan for masitinib use in progressive MS

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER THIS POSITIVE DECISION FROM THE USA ...

NextCell Pharma AB: NextCell provides strategic update on focused market progression, highlighting Hong Kong as gateway to the Chinese market

NextCell Pharma AB ("NextCell" or the "Company") provides a strategic update on its focused market progression strategy, aimed at accelerating value creation by advancing ProTrans in adult patients, w ...

As Alberta's population and employment climbs, 'Alberta's Top Employers (2026)' double down on training and development

With Alberta's population continuing to set records and employment growth leading the country, the province's best employers are investing more than ever in training, skills development and career ...

Munters Group AB (publ) (MMNNF) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call January 29, 2026 3:00 AM ESTCompany ParticipantsLine Dovarn - Head of Investor RelationsKlas ...
Pharmabiz

AB Science receives Japanese patent for use of masitinib in progressive forms of multiple sclerosis

AB Science receives Japanese patent for use of masitinib in progressive forms of multiple sclerosis: Paris Friday, January 23, 2026, 14:00 Hrs [IST] AB Science SA, a pharmaceutica ...

Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have submitted a proposed Marketing ...

Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA

BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi ...

"I gave away all my records, I started giving away my guitars, I was fantasising about my own death." The horrifying origin story behind one of the most uplifting rock so…

" Today is the greatest day I've ever known ," Billy Corgan sings at the song's outset, sounding elated at the thought of the ...
Tribal Football

Goalie Trubin sends Benfica into play-offs after nine-man Madrid win

Real Madrid will be forced to go through the play-offs in the UEFA Champions League (UCL) after a 4-2 defeat at SL Benfica ...

Mandarin High alum Carson Beck playing for national championship with University of Miami

Beck won a championship with Mandarin High School in 2018. His former offensive coordinator remembers those early days fondly ...